Espervita Therapeutics

Preclinical stage pharmaceutical development company focused on metabolic reprogramming therapies targeting areas of unmet medical need.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded May 2018
  • Employees 6
  • Incorporation Type C-corp
  • Website espervita.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free